Rare diseases
Investigational molecules
Locations
Back to Norway534 clinical trials in Oslo, Norway across 9 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in NorwayKliniske-Studier.no(opens in a new tab)AZD0120 versus standard regimens in patients with relapsed or refractory multiple myeloma
NorwayA study to compare the effectiveness of bupivacaine hydrochloride monohydrate and lidocaine hydrochloride for treating mouth sores in patients with head and neck cancer.
NorwayA study of sacituzumab tirumotecan and bevacizumab in patients with newly diagnosed advanced ovarian cancer following first-line platinum-based chemotherapy
NorwayA Phase 3 Study of Elritercept Versus Epoetin Alfa in ESA‑Naïve Adults with Lower‑Risk Myelodysplastic Syndrome Requiring Red Blood Cell Transfusions
NorwayLong‑Term Safety and Efficacy of Infigratinib in Children with Hypochondroplasia
NorwayA study to evaluate the safety and effectiveness of AAVB-039 in patients with Stargardt disease
NorwayA study comparing Rinatabart Sesutecan to other treatments in patients with endometrial cancer who have previously received platinum-based chemotherapy and PD-L1 therapy
NorwayA study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis
NorwayA study of etentamig and daratumumab compared to daratumumab, lenalidomide, and dexamethasone in adults with newly diagnosed multiple myeloma not eligible for transplant
NorwayN1T-MC-MALO: A Master Protocol for a Randomized, Controlled, Clinical Trial of Multiple Pharmacologic Agents in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease Who Are at Increased Risk of Developing Major Adverse Liver Outcomes (SYNERGY-Outcomes); N1T-MC-TZ01 Tirzepatide in participants with high-risk MASLD; N1T-MC-RT01 Retatrutide in participants with high-risk MASLD
NorwayEvaluation of Safety and Efficacy of MK-2870 and Paclitaxel in Second-Line Treatment of Advanced/Metastatic Gastroesophageal Adenocarcinoma
NorwayStudy of GSK6042981 compared to sunitinib for patients with gastrointestinal stromal tumors that spread or cannot be removed after imatinib treatment
NorwayThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on pulmonary conditions and respiratory health, including studies on idiopathic pulmonary fibrosis and respiratory syncytial virus prevention in children.
Innovative therapies being tested to improve lung function and patient outcomes.
Studies examining heart conditions and vascular health, with particular focus on heart failure and cardiovascular disease prevention.
Advanced imaging techniques and therapeutic interventions being evaluated for cardiac conditions.
Comprehensive research into various cancer treatments, including trials for gastric, esophageal, and rare cancers.
Novel therapeutic approaches combining immunotherapy with conventional treatments.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
